Validation of a longitudinally measured surrogate marker for a time-to-event endpoint

DOI10.1080/0266476022000023776zbMATH Open1121.62475OpenAlexW1966558807WikidataQ59901747 ScholiaQ59901747MaRDI QIDQ3591808FDOQ3591808

Authors: Helena Geys, Geert Molenberghs, Tomasz Burzykowski, Marc Buyse, Tony Vangeneugden, Luc Bijnens, Didier Renard 

Publication date: 11 September 2007

Published in: Journal of Applied Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/0266476022000023776

Recommendations

• Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
• Validation of surrogate markers in multiple randomized clinical trials with repeated measurements
• Evaluation of longitudinal surrogate markers
• Surrogate Marker Evaluation from an Information Theory Perspective
• The evaluation of surrogate endpoints.

Mathematics Subject Classification ID

Statistics (62-XX)

Cited In (8)

• Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints
• Center-within-trial versus trial-level evaluation of surrogate endpoints
• A review on joint models in biometrical research
• Intermediate clinical events, surrogate markers and survival
• Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
• Evaluation of longitudinal surrogate markers
• An information-theoretic approach to surrogate-marker evaluation with failure time endpoints
• Statistical evaluation of surrogate endpoints with examples from cancer clinical trials

This page was built for publication: Validation of a longitudinally measured surrogate marker for a time-to-event endpoint

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3591808)